FOXO Technologies

Curated by Signal

Provider of epigenetic biomarkers discovery and development platform

Life Sciences Technologyfoxotechnologies.com

Overview

Provider of epigenetic biomarkers discovery and development platform. The company leverages advanced machine learning and artificial intelligence to analyze complex data, particularly in the field of epigenetic biomarker research related to human longevity. It applies AI to DNA methylation to identify molecular biomarkers of human health and aging, revolutionizing underwriting and mortality prediction in the insurance industry.

Key facts

Founded: 2020
Headquarters: Minneapolis, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Platform Innovations
Provider of AI-based laparoscopic device for minimally invasive surgery
Life Sciences TechnologyNaples, United States
IMS
Provider of a wearable smart sensor for glucose monitoring
Life Sciences TechnologyOrange, United States
BillionToOne
Provider of cell-free cancer liquid biopsy test
Life Sciences TechnologySan Francisco, United States

About FOXO Technologies

What does FOXO Technologies do?

Provider of epigenetic biomarkers discovery and development platform.

Where is FOXO Technologies headquartered?

FOXO Technologies is headquartered in Minneapolis, United States.

When was FOXO Technologies founded?

FOXO Technologies was founded in 2020.

Which sector is FOXO Technologies in?

FOXO Technologies operates in Life Sciences Technology.

Who are FOXO Technologies's competitors?

Companies similar to FOXO Technologies include Platform Innovations, IMS, and BillionToOne.